Tag: Roche Tissue Diagnostics

Home / Roche Tissue Diagnostics

Categories

Pembrolizumab is approved for advanced endometrial carcinoma

April 2022: Pembrolizumab (Keytruda, Merck) was approved by the Food and Drug Administration as a single agent for patients with advanced endometrial carcinoma that is microsatellite instability-high...
roche-tissue-diagnostics

Scan the code